This statistic shows the number of drug-related admissions to publicly licensed treatment facilities in the U.S. from 2011 to 2015, by primary substance. In 2014, there were some 367 thousand heroin-related admissions in licensed treatment facilities in the United States.
Number of drug-related admissions to publicly licensed treatment facilities in the U.S. from 2011 to 2015, by primary substance
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic U.S. substance use disorder-related delivery stays rate in 2016, by urbanicity
- Basic Statistic Rate of U.S. ED visits with opioids given or prescribed at discharge 2016, by age
- Basic Statistic Distribution of U.S. opioid-related hospitalizations in women 2016, by ethnicity
- Basic Statistic Opioid-related inpatient stays under Medicare U.S. 2010 and 2015, by state
- Basic Statistic Rate of U.S. ED visits with opioids given or prescribed at discharge 2016, by gender
- Premium Statistic Rate of U.S. ED visits with opioids given or prescribed at discharge 2016, by payment
- Basic Statistic U.S. ED visits with opioids given or prescribed at discharge 2016, by diagnosis
- Basic Statistic Average cost of hospital per day by country 2015
- Basic Statistic Change in Canadian hospitals' top therapeutic class purchases 2022
- Basic Statistic Canadian hospitals' top ten therapeutic classes purchased in 2022
About the region
10
- Basic Statistic Fentanyl combination exhibits in U.S. 2015-2019
- Basic Statistic Potential fentanyl profitability compared to heroin in the U.S. as of 2017
- Premium Statistic High availability of heroin in U.S. 2010 and 2017, by region
- Basic Statistic Top U.S. states by fentanyl overdose death rate in 2016
- Premium Statistic Number of opioid units sold to retail level purchasers in the U.S. 2006-2019
- Premium Statistic Opioid narcotics dosage units lost in the U.S. 2010-2019
- Basic Statistic Purity of methamphetamine in the U.S. by half-year 2012-2019
- Basic Statistic Top CPDs dispensed in billion dosage units in the U.S. 2011-2016
- Premium Statistic Deaths from drug poisoning due to psychostimulants abuse in U.S. 2005-2018
- Premium Statistic Most distributed controlled prescription drugs in the U.S. 2014-2019
Other regions
10
- Premium Statistic Global lifetime drug use of select types of drugs as of 2017
- Premium Statistic Physicians that received opioid-manufacturer payments in New York 2013-2015
- Basic Statistic Rx oral solid opioids sold in Canada by total morphine equivalents
- Premium Statistic Users entering drug treatment in Bulgaria in 2019, by gender
- Premium Statistic Number of users entering drug treatment in Austria 2018, by drug
- Premium Statistic Users entering drug treatment in Slovenia in 2018, by drug and gender
- Premium Statistic Number of MME dispensed per capita U.S. 2014-2018
- Premium Statistic Leading pharmaceutical companies in Norway 2021, by market share
- Basic Statistic Drug-related deaths in England in 2012, by implicated drug
- Premium Statistic Number of drug users entering drug treatment services in Sweden 2017, by drug
Related statistics
10
- Basic Statistic Number of opioid and naloxone prescriptions in the U.S. 2018, by prescriber specialty
- Basic Statistic Rate of naloxone prescriptions per 100 opioid prescriptions U.S. 2018, by prescriber
- Premium Statistic Naloxone use for suspected drug overdose in EMS events in the U.S. from 2012-2016
- Basic Statistic Share of U.S. substance abuse facilities with detoxification services 2020
- Premium Statistic Share of opioid and naloxone prescriptions in the U.S. 2018, by prescriber specialty
- Premium Statistic Share of substance abuse treatment facilities in the U.S. by type 2022
- Basic Statistic Share of substance abuse treatment facilities in the U.S. by type of care 2022
- Basic Statistic Number of substance abuse pharmacotherapy facilities in the U.S. by operation 2020
- Premium Statistic Share of substance abuse treatment facilities in the U.S. by licensing 2020
- Premium Statistic Number of substance abuse treatment facilities in the U.S. by state 2020
Further related statistics
10
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
Further Content: You might find this interesting as well
Statistics
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Medicinal market growth worldwide including rebates 2009-2018
- Expenditure worldwide on diabetes by market 2013-2018
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2009-2023
- Sanofi's total assets 2007-2023
- Merck & Co - expenditure on research and development 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
Drug Enforcement Administration. (October 31, 2018). Number of drug-related admissions to publicly licensed treatment facilities in the U.S. from 2011 to 2015, by primary substance [Graph]. In Statista. Retrieved March 29, 2024, from https://www.statista.com/statistics/773553/drug-related-admissions-to-treatment-facilities-in-us-by-substance/
Drug Enforcement Administration. "Number of drug-related admissions to publicly licensed treatment facilities in the U.S. from 2011 to 2015, by primary substance." Chart. October 31, 2018. Statista. Accessed March 29, 2024. https://www.statista.com/statistics/773553/drug-related-admissions-to-treatment-facilities-in-us-by-substance/
Drug Enforcement Administration. (2018). Number of drug-related admissions to publicly licensed treatment facilities in the U.S. from 2011 to 2015, by primary substance. Statista. Statista Inc.. Accessed: March 29, 2024. https://www.statista.com/statistics/773553/drug-related-admissions-to-treatment-facilities-in-us-by-substance/
Drug Enforcement Administration. "Number of Drug-related Admissions to Publicly Licensed Treatment Facilities in The U.S. from 2011 to 2015, by Primary Substance." Statista, Statista Inc., 31 Oct 2018, https://www.statista.com/statistics/773553/drug-related-admissions-to-treatment-facilities-in-us-by-substance/
Drug Enforcement Administration, Number of drug-related admissions to publicly licensed treatment facilities in the U.S. from 2011 to 2015, by primary substance Statista, https://www.statista.com/statistics/773553/drug-related-admissions-to-treatment-facilities-in-us-by-substance/ (last visited March 29, 2024)
Number of drug-related admissions to publicly licensed treatment facilities in the U.S. from 2011 to 2015, by primary substance [Graph], Drug Enforcement Administration, October 31, 2018. [Online]. Available: https://www.statista.com/statistics/773553/drug-related-admissions-to-treatment-facilities-in-us-by-substance/